Arvinas (ARVN) FCF Margin (2017 - 2026)

Arvinas (ARVN) recorded quarterly FCF Margin of 443.59% in Q1 2026, down 37.72% quarter-over-quarter from 322.11% in Q4 2025, and down 39645.0% on a YoY basis from N/an in Q1 2025.

Arvinas (ARVN) FCF Margin (2017 - 2026) Analysis & Trends

Arvinas' FCF Margin history runs 10 years deep, the most recent figure standing at 443.59% for Q1 2026.

  • In Q1 2026, FCF Margin fell 39645.0% year-over-year to 443.59%; the TTM figure through Mar 2026 stood at 286.24% (down 22707.0% YoY), while the FY2025 annual figure was 104.99%, down 586.0% from the prior year.
  • FCF Margin was 443.59% for Q1 2026 at Arvinas, down from 322.11% in the prior quarter.
  • In the past five years, FCF Margin ranged from a high of 186.31% in Q4 2023 to a low of 443.59% in Q1 2026.
  • Historically, FCF Margin has averaged 195.54% across 5 years, with a median of 200.0% in 2022.
  • Biggest YoY gain for FCF Margin was 65354 bps in 2022; the steepest drop was 754301 bps in 2022.
  • A 5-year view of FCF Margin shows it stood at 187.83% in 2022, then surged by 199 bps to 186.31% in 2023, then sank by 177 bps to 142.57% in 2024, then slumped by 126 bps to 322.11% in 2025, then sank by 38 bps to 443.59% in 2026.
  • The last three FCF Margin figures came in at 443.59% (Q1 2026), 322.11% (Q4 2025), and 141.29% (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) FCF Margin (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn -3.98%
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 43.35%
9 Abivax 91.96 Bn 91.96 Bn - -
10 Arvinas 492.16 Mn -122.74 Mn - -443.59%

Historic Data

Download Data
DateValue
Mar 31, 2026 -443.59%
Dec 31, 2025 -322.11%
Sep 30, 2025 -141.29%
Jun 30, 2025 -432.59%
Mar 31, 2025 -47.14%
Dec 31, 2024 -142.57%
Sep 30, 2024 -125.68%
Jun 30, 2024 64.71%
Mar 31, 2024 -385.38%
Dec 31, 2023 186.31%
Sep 30, 2023 -252.02%
Jun 30, 2023 -161.47%
Mar 31, 2023 -284.00%
Dec 31, 2022 -187.83%
Sep 30, 2022 -200.00%
Jun 30, 2022 -233.73%
Mar 31, 2022 -215.85%
Dec 31, 2021 -121.39%
Sep 30, 2021 7,343.01%
Jun 30, 2021 -887.27%